VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by maintaining kidney function over a...
Search results for "sales"
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Yuhan Ramps Up OTC Magnesium Push with Dual-Campaign for Liquid and High-Dose 'MagV'
If your lower eyelid twitches or you experience sudden leg cramps, it is common to assume a magnesium deficiency is to...
Sterilized Yet Moldy? Why Ice Water Purifiers Keep Facing Hygiene Scares
Concerns are mounting among households using ice water purifiers as consumer complaints continue to surface online...
Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries
Daewoong Pharmaceutical’s botulinum toxin product Nabota has entered Kuwait, expanding its Middle East footprint to...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway
"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
Ilyang Pharmaceutical Commits 17.6 Billion Won to China Comeback with Flagship Wonbi-D
Ilyang Pharmaceutical is mounting a fresh push into the Chinese market, reviving a business operation that had been...
"1 Million Won a Month Covers Everything"? The Hidden Cost Trap in Long-Term Senior Care
"If you pay in the 1 million won-a-month range, we’ll take care of everything." It is a familiar sales pitch at many...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...